MedPath

Exact Sciences' colon cancer blood test shows initial promise - STAT News

Exact Sciences' blood-based colon cancer test detected 88.3% of cancers and correctly returned a negative result 90.1% of the time, with 31.2% detection of advanced precancers. This is the first data shared on the test, presented at the European Society for Medical Oncology conference. A larger study is ongoing, with FDA approval expected in the first half of next year.


Reference News

Exact Sciences' colon cancer blood test shows initial promise - STAT News

Exact Sciences' blood-based colon cancer test detected 88.3% of cancers and correctly returned a negative result 90.1% of the time, with 31.2% detection of advanced precancers. This is the first data shared on the test, presented at the European Society for Medical Oncology conference. A larger study is ongoing, with FDA approval expected in the first half of next year.

© Copyright 2025. All Rights Reserved by MedPath